Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Department of Medicine, Lankenau Hospital, Philadelphia, Pennsylvania.
Am J Med Sci. 2020 Dec;360(6):650-655. doi: 10.1016/j.amjms.2020.07.019. Epub 2020 Jul 16.
Inappropriate antibiotic therapy in sepsis is associated with poor outcomes, clinicians often provide routine coverage for multidrug resistant (MDR) bacteria. However, these regimens may contribute to problems related to antibiotic overuse. To understand the incidence and related factors of multidrug resistant bacterial infections in ED patients with sepsis, we examined how often patients with sepsis in our emergency department had MDR infections. We also explored risk factors for, and outcomes from, MDR bacterial infections.
We reviewed records of patients presenting to our emergency department (ED) meeting criteria for severe sepsis or septic shock from March 2012 to July 2013. Patient demographics, comorbidities, preadmission location, and APACHE II scores were analyzed, as were clinical outcomes.
A total of 191 episodes were examined. 108 (57%) cases were culture-positive, and of these, 23 (12.0%) had an MDR pathogen recovered. Among patients with positive cultures, MDR patients used mechanical ventilation more often 29% vs. 52% (P = 0.03) and had longer mean ICU and hospital length of stays: 4.0 vs 9.3 (P < 0.08) and 10.6 vs 20.8 (P = 0.01), respectively. We did not identify statistically significant predictors of MDR infection.
The overall number of infections due to MDR bacteria was low, and MDR gram-negative infections were uncommon. The use of multiple empiric antibiotics for resistant gram-negative infections in the ED may be beneficial in only a small number of cases. Additionally, empiric coverage for vancomycin-resistant enterococci may need to be considered more often. Larger studies may help further elucidate the rates of MDR infections in ED patients, and identify specific risk factors to rationally guide empiric antibiotic treatment.
脓毒症中不适当的抗生素治疗与不良结局相关,临床医生通常会为多重耐药(MDR)细菌提供常规治疗。然而,这些方案可能会导致与抗生素过度使用相关的问题。为了了解急诊科脓毒症患者中多重耐药菌感染的发生率和相关因素,我们检查了我们急诊科脓毒症患者中 MDR 感染的发生频率。我们还探讨了 MDR 细菌感染的危险因素和结局。
我们回顾了 2012 年 3 月至 2013 年 7 月期间符合严重脓毒症或感染性休克标准的急诊科(ED)患者的记录。分析了患者的人口统计学、合并症、入院前位置和急性生理学与慢性健康状况评分系统 II(APACHE II)评分,以及临床结局。
共检查了 191 例病例。108 例(57%)为培养阳性,其中 23 例(12.0%)培养出 MDR 病原体。在培养阳性的患者中,MDR 患者更常使用机械通气(29% vs. 52%,P=0.03),ICU 和住院的平均时长更长:分别为 4.0 天 vs. 9.3 天(P<0.08)和 10.6 天 vs. 20.8 天(P=0.01)。我们没有发现 MDR 感染的统计学显著预测因素。
MDR 细菌引起的感染总数较低,MDR 革兰氏阴性菌感染并不常见。在急诊科对耐药革兰氏阴性菌感染使用多种经验性抗生素可能仅在少数情况下有益。此外,可能需要更频繁地考虑万古霉素耐药肠球菌的经验性覆盖。更大的研究可能有助于进一步阐明急诊科患者 MDR 感染的发生率,并确定具体的危险因素,以合理指导经验性抗生素治疗。